Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Clinical trial NCT02777931 · COMPLETED

Trial details

NCT number: NCT02777931
Sponsor: Aevi Genomic Medicine, LLC, a Cerecor company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity

Start date: 2016-06-01
Primary completion: 2017-02-10
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.